MedTrace Logo

Effect of 2% Lignocaine Solution in Pain During Removal of Nasal Pack

NCT03602287 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2018-09-24

No results posted yet for this study

Summary

To evaluate the efficacy of rehydration of Merocel nasal packs with 2% Lignocaine on reducing pain and discomfort during nasal pack removal in patients undergoing septoplasty.

Conditions

  • Nasal Pack Removal

Interventions

DRUG

Lignocaine 2% Injection 20Ml Vial (Product)

2.5 ml of 2% of lignocaine is diluted with 2.5 ml of distilled water, and the 5ml solution will be injected into the Merocel pack 15 minutes before removal of the pack

DRUG

Normal saline

5 ml of normal saline was injected into the Merocel pack 15 minutes before removal of the pack

Sponsors & Collaborators

  • Dhulikhel Hospital

    lead OTHER

Principal Investigators

  • Ashish Dhakal · Dhulikhel Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2018-08-01
Completion
2018-08-01

Countries

  • Nepal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03602287 on ClinicalTrials.gov